Linda van der Tol

Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease

Bouwien E. Smid, Linda van der Tol, Marieke Biegstraaten et al. · Journal of Medical Genetics · 2015 · 163 citations · Full text

Life Sciences, Genetics, Pathology +13

Chronic kidney disease and an uncertain diagnosis of Fabry disease: Approach to a correct diagnosis

Linda van der Tol, Einar Svarstad, Alberto Ortíz et al. · Molecular Genetics and Metabolism · 2014 · 64 citations

Medicine, Clinical Sciences, Nephrology +11

Uncertain Diagnosis of Fabry Disease in Patients with Neuropathic Pain, Angiokeratoma or Cornea Verticillata: Consensus on the Approach to Diagnosis and Follow-Up

Linda van der Tol, David Cassiman, Gunnar Houge et al. · JIMD Reports · 2014 · 49 citations · Full text

Medicine, Neurology, Pathology +13

Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long‐term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans

Minke H. de Ru, Linda van der Tol, Naomi van Vlies et al. · Journal of Inherited Metabolic Disease · 2012 · 48 citations · Full text

Life Sciences, Biochemistry, Pharmacokinetics +14

In Patients with an α-Galactosidase A Variant, Small Nerve Fibre Assessment Cannot Confirm a Diagnosis of Fabry Disease

Linda van der Tol, Camiel Verhamme, Ivo N. van Schaik et al. · JIMD Reports · 2015 · 11 citations · Full text

Life Sciences, Genetics, Neurology +14